Centene Corp Rating Reiterated by Credit Suisse (CNC)
Centene Corp (NYSE:CNC)‘s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Monday. They currently have a $83.00 target price on the stock, up from their previous target price of $72.00. Credit Suisse’s price target points to a potential upside of 11.97% from the company’s current price.
Shares of Centene Corp (NYSE:CNC) traded up 0.88% during mid-day trading on Monday, hitting $74.78. The stock had a trading volume of 366,046 shares. Centene Corp has a 1-year low of $48.89 and a 1-year high of $75.90. The stock’s 50-day moving average is $70.71 and its 200-day moving average is $63.23. The company has a market cap of $4.313 billion and a P/E ratio of 24.27.
Centene Corp (NYSE:CNC) last announced its earnings results on Tuesday, April 22nd. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.13. The company had revenue of $3.35 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 31.9% on a year-over-year basis. On average, analysts predict that Centene Corp will post $3.71 earnings per share for the current fiscal year.
CNC has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Centene Corp in a research note on Monday. They now have a $71.00 price target on the stock, up previously from $69.00. Separately, analysts at Oppenheimer raised their price target on shares of Centene Corp from $78.00 to $81.00 in a research note on Monday. They now have an “outperform” rating on the stock. Finally, analysts at Susquehanna raised their price target on shares of Centene Corp from $80.00 to $85.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $73.94.
Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.